Moleculin Biotech Inc (MBRX)
2.90
+0.07
(+2.47%)
USD |
NASDAQ |
Nov 22, 15:29
Moleculin Biotech Price: 2.90 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 21, 2024 | 2.64 | 2.84 | 2.63 | 2.83 | 17142.00 |
Nov 20, 2024 | 2.84 | 2.84 | 2.61 | 2.67 | 33688.00 |
Nov 19, 2024 | 2.60 | 2.77 | 2.52 | 2.615 | 109479.0 |
Nov 18, 2024 | 2.71 | 2.91 | 2.47 | 2.52 | 51188.00 |
Nov 15, 2024 | 3.18 | 3.18 | 2.70 | 2.71 | 87804.00 |
Nov 14, 2024 | 2.60 | 3.33 | 2.52 | 3.09 | 533199.0 |
Nov 13, 2024 | 2.51 | 2.63 | 2.50 | 2.51 | 33766.00 |
Nov 12, 2024 | 2.58 | 2.73 | 2.54 | 2.64 | 66480.00 |
Nov 11, 2024 | 2.54 | 2.55 | 2.435 | 2.51 | 33923.00 |
Nov 08, 2024 | 2.38 | 2.56 | 2.350 | 2.55 | 48118.00 |
Nov 07, 2024 | 2.32 | 2.44 | 2.29 | 2.34 | 26763.00 |
Nov 06, 2024 | 2.36 | 2.516 | 2.30 | 2.30 | 31470.00 |
Nov 05, 2024 | 2.41 | 2.463 | 2.37 | 2.44 | 6677.00 |
Nov 04, 2024 | 2.65 | 2.65 | 2.36 | 2.45 | 29618.00 |
Nov 01, 2024 | 2.56 | 2.65 | 2.40 | 2.45 | 23453.00 |
Oct 31, 2024 | 2.57 | 2.645 | 2.54 | 2.60 | 16815.00 |
Oct 30, 2024 | 2.57 | 2.658 | 2.51 | 2.54 | 15839.00 |
Oct 29, 2024 | 2.60 | 2.71 | 2.50 | 2.62 | 24622.00 |
Oct 28, 2024 | 2.79 | 2.79 | 2.573 | 2.62 | 10622.00 |
Oct 25, 2024 | 2.55 | 2.70 | 2.55 | 2.575 | 9008.00 |
Oct 24, 2024 | 2.55 | 2.635 | 2.47 | 2.54 | 10004.00 |
Oct 23, 2024 | 2.55 | 2.610 | 2.48 | 2.55 | 16526.00 |
Oct 22, 2024 | 2.73 | 2.76 | 2.54 | 2.55 | 18655.00 |
Oct 21, 2024 | 2.58 | 2.85 | 2.58 | 2.67 | 52524.00 |
Oct 18, 2024 | 2.425 | 2.65 | 2.35 | 2.585 | 34144.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.195
Minimum
Aug 08 2024
132.30
Maximum
Apr 16 2020
35.67
Average
22.35
Median
Feb 04 2022
Price Benchmarks
Agilent Technologies Inc | 133.89 |
Seelos Therapeutics Inc | 0.3001 |
Cara Therapeutics Inc | 0.3065 |
Citius Pharmaceuticals Inc | 0.13 |
NovaBay Pharmaceuticals Inc | 0.6841 |
Price Related Metrics
Price to Book Value | 1.164 |
Earnings Yield | -406.0% |
Market Cap | 8.706M |